See also this year's filing and all EDGAR filings for this company.
PDF Report 0001618835_2022_Evofem_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001618835, Evofem Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 30,140,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,774,000 |
| 3 | remainder_Assets | 6,598,000 |
| 4 | LiabilitiesCurrent | 137,663,000 |
| 5 | LiabilitiesNoncurrent | 4,424,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 4,055,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,863,187 |
| 9 | ResearchAndDevelopmentExpense | 30,076,482 |
| 10 | remainder_Expenses | 113,717,663 |
| 11 | remainder_Revenues | 8,244,000 |
| 12 | remainder_NetIncome | -38,373,995 |
| 13 | remainder_ComprehensiveNetIncome | 5,089,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 42,512,000 |
| 1 | Liabilities | 142,087,000 |
| 2 | Expenses | 172,712,332 |
| 3 | Revenues | 8,244,000 |
| 4 | StockholdersEquity | -99,575,000 |
| 5 | NetIncome | -202,842,327 |
| 6 | ComprehensiveNetIncome | -200,297,827 |
| 7 | BaseVar | 204,509,164 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.52 |
| 9 | EconomicCapitalRatio | 0.275 |
Edgar->Model Mapping
Feature Distribution
Change over Time
